Only 16 spots left

~16 spots leftby Apr 2026

Prediction of Jaundice in Term Infants

Recruiting in Palo Alto (17 mi)

+12 other locations

Overseen byEdward F. Donovan, MD

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: NICHD Neonatal Research Network

No Placebo Group

Trial Summary

What is the purpose of this trial?

The objective of this study was to describe total bilirubin production in healthy term infants as a means of understanding the differences in jaundice pigment production associated with various common clinical circumstances.

Research Team

Jon E. Tyson, MD

Principal Investigator

University of Texas

Richard A. Ehrenkranz, MD

Principal Investigator

Yale University

William Oh, MD

Principal Investigator

Brown University, Women & Infants Hospital of Rhode Island

Raymond Bain, PhD

Principal Investigator

George Washington University

David K. Stevenson, MD

Principal Investigator

Stanford University

Seetha Shankaran, MD

Principal Investigator

Wayne State University

Charles R. Bauer, MD

Principal Investigator

University of Miami

Barbara J. Stoll, MD

Principal Investigator

Emory University

Avroy A. Fanaroff, MD

Principal Investigator

Case Western Reserve University

James A. Lemons, MD

Principal Investigator

Indiana University

Sheldon B. Korones, MD

Principal Investigator

University of Tennessee

Lu-Ann Papile, MD

Principal Investigator

University of New Mexico

Edward F. Donovan, MD

Principal Investigator

Children's Hospital Medical Center, Cincinnati

Eligibility Criteria

Inclusion Criteria

Gestational age >37 weeks

Infants born via cesarean delivery (to ensure subjects would still be hospitalized and available for ETCOc measurement and blood sampling on day 3 postpartum)

Delivery within each center's scheduled recruitment period (to maximize nursing availability and minimize cost)

See 1 more